Patents by Inventor Robert Kossmann

Robert Kossmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250079022
    Abstract: Techniques for patient population flow modeling are disclosed, where such modeling can provide insights for future trends among a patient population, e.g., to facilitate allocation of resources for the patient population or to inform treatment recommendations for patients. A flow model can be used on dialysis patient populations where the patients are grouped into a compartment according to a certain criterion (or given criteria), where each compartment corresponds to the number of patients in each group, and where the number of compartments can vary depending on the given criteria. A model can then be used to describe the transition rates between the different compartments, as well as influx and efflux within each compartment. Such a model can be used, by way of example, to investigate the impact of sodium-glucose co-transporter 2 (SGLT2) inhibitors on the population dynamics of end-stage renal disease patients.
    Type: Application
    Filed: November 16, 2024
    Publication date: March 6, 2025
    Inventors: Alhaji Cherif, Peter Kotanko, Nina Muellers, Zdenek Cerman, Julian Dreismeier, Robert Kossmann
  • Patent number: 11738125
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: August 29, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20210338908
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: May 14, 2021
    Publication date: November 4, 2021
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Patent number: 11007310
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: May 18, 2021
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20200206403
    Abstract: Systems and methods for estimating the post-treatment ultrafiltration rate of a patient are provided. A medical device can be configured to determine an estimated post-treatment ultrafiltration rate based on one or more values associated with a patient prepared to undergo treatment with the medical device. The medical device can also be configured to compare the estimated post-treatment ultrafiltration rate with one or more threshold values. The medical device can be configured to have an alert module, which can be activated when the estimated post-treatment ultrafiltration rate exceeds the one or more threshold values.
    Type: Application
    Filed: December 28, 2018
    Publication date: July 2, 2020
    Inventors: Michael Singer, Shawn Sobelman, Robert Kossmann, Martin Joseph Crnkovich, Roland Levin
  • Publication number: 20180000394
    Abstract: Embodiments of the disclosure provide a method and system for providing a diagnostic vascular window that may be used in real time to monitor a patient's fluid conditions in a variety of settings. The diagnostic vascular window may, for example, be used pre-surgery, during surgery, and post-surgery to determine whether a correct type and dose of diuretic drugs are being used for the patient. The diagnostic vascular window utilizes low flow accesses to view blood/fluids leaving and entering the patient's body. In addition, the same amount of fluids leaving the body enters the body, so there are no fluid losses or gains within the diagnostic vascular window. The low flow accesses in conjunction with a monitoring system allows for real-time measurements of blood parameters without fluid loss.
    Type: Application
    Filed: June 30, 2017
    Publication date: January 4, 2018
    Inventors: Michael Black, Louis L. Barrett, Peter Kotanko, Robert Kossmann